Report cover image

Global Olprinone Hydrochloride Injection Market Growth 2026-2032

Publisher LP Information, Inc.
Published Jan 15, 2026
Length 113 Pages
SKU # LPI20717153

Description

The global Olprinone Hydrochloride Injection market size is predicted to grow from US$ 478 million in 2025 to US$ 730 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.

Oprinone hydrochloride injection is a cardiovascular drug whose main ingredient is oprinone hydrochloride, which is a phosphodiesterase III inhibitor. It improves heart function by increasing myocardial contractility and dilating blood vessels. It is mainly used to treat acute heart failure and low cardiac output syndrome. It can quickly relieve symptoms and improve patients' heart function and hemodynamic status.

United States market for Olprinone Hydrochloride Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Olprinone Hydrochloride Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Olprinone Hydrochloride Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Olprinone Hydrochloride Injection players cover Shenyang Shuangding Pharmaceutical Co., Ltd., Sinopharm Rongsheng Pharmaceutical Co., Ltd., Jichuang Pharmaceutical Group Co., Ltd., Wuhu Yangyan Pharmaceutical Co., Ltd., Jilin Sichang Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Olprinone Hydrochloride Injection Industry Forecast” looks at past sales and reviews total world Olprinone Hydrochloride Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Olprinone Hydrochloride Injection sales for 2026 through 2032. With Olprinone Hydrochloride Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Olprinone Hydrochloride Injection industry.

This Insight Report provides a comprehensive analysis of the global Olprinone Hydrochloride Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Olprinone Hydrochloride Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Olprinone Hydrochloride Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Olprinone Hydrochloride Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Olprinone Hydrochloride Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Olprinone Hydrochloride Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
10 Pieces/Box
5 Pieces/Box

Segmentation by Application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Shenyang Shuangding Pharmaceutical Co., Ltd.
Sinopharm Rongsheng Pharmaceutical Co., Ltd.
Jichuang Pharmaceutical Group Co., Ltd.
Wuhu Yangyan Pharmaceutical Co., Ltd.
Jilin Sichang Pharmaceutical Co., Ltd.
Shandong Qidu Pharmaceutical Co., Ltd.
Zhongfu Pharmaceutical Co., Ltd.
Hunan Hengsheng Pharmaceutical Co., Ltd.
Shanxi Deyuantang Pharmaceutical Co., Ltd.
Ruiyang Pharmaceutical Co., Ltd.
Dequan Pharmaceutical (Jiangsu) Co., Ltd.
Cayman Chemical
Vinci Biochem srl
BioHippo
DC Chemicals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Olprinone Hydrochloride Injection market?

What factors are driving Olprinone Hydrochloride Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Olprinone Hydrochloride Injection market opportunities vary by end market size?

How does Olprinone Hydrochloride Injection break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

113 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Olprinone Hydrochloride Injection by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Olprinone Hydrochloride Injection by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us